A group of 9 patients, average age 62, with symptoms of urination disorders, who underwent surgical intervention for infravesical obstruction (IVO), were under observation. Patients underwent urodynamic examination in the volume of liquid static profilometry using a specialized standard 10F catheter before and after surgery. The urodynamic system of domestic production LEVELEST SURD-02 was used. Based on the data obtained, the reflex mechanism of pelvic floor tone was analyzed in patients with prostate adenoma operated by transurethral enucleation.

Abstract BackgroundCombined obesity and Crohn's disease (CD) are becoming an increasing issue worldwide and in Saudi Arabia. In this series, we evaluate the feasibility and the outcomes of laparoscopic sleeve gastrectomy (LSG) in obese patients with CD.MethodsThis series is a retrospective analysis of our database with patients undergoing LSG from 2015 to 2020. Obese patients with CD were included.ResultsSixty‐one obese patients with CD underwent LSG with a mean preoperative body mass index (BMI) of 42.6 ± 4.3. The mean excess weight loss (% EWL) at 3, 6, 9 months, and 1 year was 41 ± 1.8, 51 ± 2.3, 67 ± 1.2, and 71 ± 3.1, respectively. There were no identified intra‐operative complications. The mean intra‐operative time was 40 ± 20. Only one patient developed a postoperative leak and was treated conservatively. No late postoperative complications were reported. During the follow‐up period, 6 (9.8%) patients were noted to have CD‐related medications discontinued (azathioprine and sulfasalazine), and 8 (13.1%) patients showed a reduction in the dosage of their medications.ConclusionLSG appears to be a safe and effective option for carefully selected patients with CD.

Sodium or calcium polystyrene sulfonate is a cation-exchange resin commonly administered to treat hyperkalaemia. Its side effects include aspiration pneumonitis and digestive complications, such as nausea, vomiting and constipation. Whereas colonic necrosis and perforation are rare complications associated with the medication. Here we describe a case of calcium polystyrene sulfonate-induced colonic necrosis and perforation to remind clinicians of these rare, but potentially lethal, complications associated with this commonly used medication.

Abstract The application of biodegradable pancreatic stent in pancreatoduodenectomy has rarely been studied. Archimedes biodegradable stent is a newly designed CE‐approved biodegradable stent. We conducted a retrospective cohort study to evaluate the performance of this stent in patients undergoing pancreatoduodenectomy. Clinical outcomes of these patients were reviewed. Among nine patients in this study, six (66.7%) slow‐degrading, two (22.2%) medium‐degrading, and one (11.1%) fast‐degrading stents were used. Technical success rate was 100%. There was no hospital mortality. Four patients (44.4%) developed clinically relevant post‐operative pancreatic fistula (POPF). Proximal migration of stent occurred in two patients (22%) who were managed conservatively. Five stents (55.5%) degraded within the expected degradation period. In conclusion, the use of Archimedes biodegradable stent in pancreatoduodenectomy is technically feasible. Future study is needed to evaluate its potential efficacy of reducing POPF.

Background Thyroid carcinoma arising from thyroglossal duct cyst is rare. Papillary thyroid carcinoma is the most frequent subtype but its biological behaviour, such as pattern of nodal spread, is largely elusive. Method We report one case of locally advanced papillary carcinoma arising from thyroglossal duct cyst with subclinical cervical level I lymph node metastasis which is an unexpected drainage area for its counterpart from the thyroid. Results Sistrunk operation, total thyroidectomy and bilateral cervical level I lymph node dissection were performed. I131 ablation was administered postoperatively. Patient remained disease free after a follow-up of 7 years. Conclusion The reported case shed light on the nodal spread from thyroglossal duct cyst cancer and has bearing on the plan of surgical management.

Abstract BACKGROUNDThe indications for bariatric surgery revision are weight loss failure, complications or weight regain so laparoscopic one anastomosis gastric bypass (LOAGB) is a promising revisional bariatric procedure for failed laparoscopic sleeve gastrectomy (LSG).AIM OF STUDYThe aim was to evaluate LOAGB as a revisional bariatric procedure for failed LSG regarding weight loss, improvement in comorbidities and complications.PATIENTS AND METHODSThis prospective study was carried out at the Gastrointestinal and Laparoscopic Surgery Unit, General Surgery Department, Tanta University, between Jan 2018 and June 2019. It included 40 patients who underwent LOAGB as a revisional bariatric procedure for failed LSG.RESULTSThe study population included 32 females and 8 males with a mean age of 28.20 ± 7.22 years. The mean preoperative body mass index (BMI) was 45.54 ± 5.24 kg/m2. The mean operative time was 80.59 ± 35.42 min and the mean postoperative hospital stay was 3.35 days. Neither conversion to open or to other bariatric procedures, nor mortality occurred. Revisional surgery was performed 45 ± 10.5 months after primary LSG Concomitant procedures were cholecystectomy in 4 patients (10%) and re‐sleeve for wide proximal pouch occurred in 15 patients (37.5%). Early complications were encountered in 4 patients (10%), intraluminal bleeding was recorded in 1 patient (2.5%). Late complications included 8 patients (20%). The mean postoperative excess body weight loss percent achieved was 45.23 ± 12.35 at 1 year, 58.85 ± 14.60 at 2 years. The mean BMI achieved was 34.52 ± 4.26 at 1 year, 29.37 ± 6.95 at 2 years.CONCLUSIONLaparoscopic one anastomosis gastric bypass is an easy, safe and effective revisional bariatric procedure for failed LSG producing satisfactory weight loss and improvement or resolution of comorbidities with low perioperative complications.